Related Experiment Videos
[Blood culture negative endocarditis: a diagnostic challenge]
1Clinique de Médicine, Hôpital Cantonal, Fribourg. waellif@hopcantfr.ch
Revue Medicale Suisse
|November 12, 2005
Summary
Blood culture negative endocarditis (BCNE) is challenging to diagnose, often due to prior antibiotic use. Molecular tools like 16S rRNA PCR offer promising solutions for identifying causative agents and improving patient outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Molecular Diagnostics
Context:
- Blood culture negative endocarditis (BCNE) represents a significant clinical challenge, accounting for approximately 5% of endocarditis cases.
- Delayed diagnosis and treatment initiation in BCNE can negatively impact patient outcomes.
- Common etiologies include prior antimicrobial drug administration and the presence of slow-growing or non-cultivable organisms.
Purpose:
- To highlight the diagnostic difficulties in BCNE.
- To emphasize the critical role of identifying the etiologic agent in BCNE management.
- To explore the potential of molecular diagnostic tools in improving BCNE diagnosis.
Summary:
- BCNE diagnosis is often delayed, most commonly due to pre-sampling antimicrobial therapy.
- Slow-growing or non-cultivable organisms also contribute to negative blood cultures in endocarditis.
- Broad-range 16S rRNA PCR followed by sequencing and microorganism-specific PCR are promising molecular techniques for BCNE etiology identification.
Impact:
- Molecular tools like 16S rRNA PCR show promise for accurate and timely BCNE diagnosis.
- Successful identification of causative agents can lead to more targeted antimicrobial therapy.
- Incorporating molecular techniques into diagnostic criteria may improve the management and outcomes of BCNE patients.